Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Sirtex Medical Ltd

+ Add to Watchlist

SRX:AU

19.5100 AUD 0.8500 4.17%

As of 01:49:34 ET on 05/06/2015.

Snapshot for Sirtex Medical Ltd (SRX)

Open: 20.0000 Day's Range: 19.3600 - 20.1600 Volume: 739,659
Previous Close: 20.3600 52wk Range: 14.8000 - 39.9500 1-Yr Rtn: +22.39%

Stock Chart for SRX

No chart data available.
  • SRX:AU 19.5300
  • 1D
  • 1M
  • 1Y
20.3600
Interactive SRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SRX

Current P/E Ratio (ttm) 36.1655
Estimated P/E(06/2015) 30.9810
Relative P/E vs. AS51 1.7027
Earnings Per Share (AUD) (ttm) 0.5414
Est. EPS (AUD) (06/2015) 0.6320
Est. PEG Ratio 1.2543
Market Cap (M AUD) 1,106.86
Shares Outstanding (M) 56.53
30 Day Average Volume 536,301
Price/Book (mrq) 9.2707
Price/Sale (ttm) 7.2633
Dividend Indicated Gross Yield 1.02%
Cash Dividend (AUD) 0.1400
Dividend Ex-Date 10/03/2014
5 Year Dividend Growth 14.87%
Next Earnings Announcement 08/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SRX

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for SRX

Sirtex Medical Limited is a medical company which researches, develops and commercializes medical products for the treatment of liver cancer. The Company is based in Western Australia and markets its products throughout the world. The Company's products include "SIR-Spheres," which uses micro-particle technology to treat liver cancer.

Gilman WongCEO/Exec Dir/Mng DirDarren SmithCFO/Secretary
David CadeChief Medical OfficerNigel LangeCEO:Europe
More Company Profile & Key Executives for SRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil